WO2007109797A3 - Cancer detection reagents and uses in pathology and diagnostics and cancer cell death - Google Patents
Cancer detection reagents and uses in pathology and diagnostics and cancer cell death Download PDFInfo
- Publication number
- WO2007109797A3 WO2007109797A3 PCT/US2007/064822 US2007064822W WO2007109797A3 WO 2007109797 A3 WO2007109797 A3 WO 2007109797A3 US 2007064822 W US2007064822 W US 2007064822W WO 2007109797 A3 WO2007109797 A3 WO 2007109797A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cancer
- detection reagents
- diagnostics
- subject
- pathology
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/16—Primer sets for multiplex assays
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Cancer detection reagents have been identified through comparison of cancer mRNAs with the transcriptome of healthy cells. These cancer detection reagents may be used for a variety of purposes including diagnostics and targeted destruction of cancer cells. In diagnostic applications, peripheral blood or other tissue samples from a subject may be analyzed to generate a cancer profile for that subject. That profile may then be used to guide cancer treatment with known agents. It may also be used to generate agents capable of killing the subject's cancer cells in a targeted manner. These agents may include antibodies and siRNA, RNAi, or antisense RNA.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07780473A EP2004862A2 (en) | 2006-03-23 | 2007-03-23 | Cancer detection reagents and uses in pathology and diagnostics and cancer cell death |
CA002646194A CA2646194A1 (en) | 2006-03-23 | 2007-03-23 | Cancer detection reagents and uses in pathology and diagnostics and cancer cell death |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US74369906P | 2006-03-23 | 2006-03-23 | |
US60/743,699 | 2006-03-23 | ||
US74726006P | 2006-05-15 | 2006-05-15 | |
US60/747,260 | 2006-05-15 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2007109797A2 WO2007109797A2 (en) | 2007-09-27 |
WO2007109797A3 true WO2007109797A3 (en) | 2008-10-02 |
Family
ID=38523333
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2007/064822 WO2007109797A2 (en) | 2006-03-23 | 2007-03-23 | Cancer detection reagents and uses in pathology and diagnostics and cancer cell death |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP2004862A2 (en) |
CA (1) | CA2646194A1 (en) |
WO (1) | WO2007109797A2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3330278A1 (en) | 2012-02-08 | 2018-06-06 | Ionis Pharmaceuticals, Inc. | Modulation of rna by repeat targeting |
AU2017339561B2 (en) | 2016-10-07 | 2024-02-01 | Secarna Pharmaceuticals Gmbh & Co. Kg | Novel approach for treating cancer |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006081248A2 (en) * | 2005-01-25 | 2006-08-03 | Sky Genetics, Inc. | Cancer markers and detection methods |
-
2007
- 2007-03-23 EP EP07780473A patent/EP2004862A2/en not_active Withdrawn
- 2007-03-23 WO PCT/US2007/064822 patent/WO2007109797A2/en active Application Filing
- 2007-03-23 CA CA002646194A patent/CA2646194A1/en not_active Abandoned
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006081248A2 (en) * | 2005-01-25 | 2006-08-03 | Sky Genetics, Inc. | Cancer markers and detection methods |
Non-Patent Citations (12)
Title |
---|
AOUACHERIA ABDEL ET AL: "In silico whole-genome scanning of cancer-associated nonsynonymous SNPs and molecular characterization of a dynein light chain tumour variant.", ONCOGENE 8 SEP 2005, vol. 24, no. 40, 8 September 2005 (2005-09-08), pages 6133 - 6142, XP002478753, ISSN: 0950-9232 * |
AOUACHERIA ABDEL ET AL: "In silico whole-genome screening for cancer-related single-nucleotide polymorphisms located in human mRNA untranslated regions", BMC GENOMICS, BIOMED CENTRAL, LONDON, GB, vol. 8, no. 1, 3 January 2007 (2007-01-03), pages 2, XP021022322, ISSN: 1471-2164 * |
AOUACHERIA ABDEL ET AL: "Supplementary file 1", ONCOGENE 8 SEP 2005, vol. 24, no. 40, 8 September 2005 (2005-09-08), pages 1 - 12, ISSN: 0950-9232 * |
CLIFFORD ROBERT ET AL: "Expression-based genetic/physical maps of Single-Nucleotide Polymorphisms identified by the Cancer Genome Anatomy Project", GENOME RESEARCH, vol. 10, no. 8, August 2000 (2000-08-01), pages 1259 - 1265, XP002478758, ISSN: 1088-9051 * |
DAVIES H ET AL: "MUTATIONS OF THE BRAF GENE IN HUMAN CANCER", NATURE, NATURE PUBLISHING GROUP, LONDON, GB, vol. 417, no. 6892, 27 June 2002 (2002-06-27), pages 949 - 954, XP001188240, ISSN: 0028-0836 * |
LOKTIONOV ALEXANDRE: "Common gene polymorphisms, cancer progression and prognosis", CANCER LETTERS, vol. 208, no. 1, 10 May 2004 (2004-05-10), pages 1 - 33, XP002478756, ISSN: 0304-3835 * |
PARK JANE ET AL: "Mutation profiling of mismatch repair-deficient colorectal cncers using an in silico genome scan to identify coding microsatellites.", CANCER RESEARCH 1 MAR 2002, vol. 62, no. 5, 1 March 2002 (2002-03-01), pages 1284 - 1288, XP002478755, ISSN: 0008-5472 * |
QIU PING ET AL: "Additional file 1, Table 2", BMC CANCER, BIOMED CENTRAL, LONDON, GB, vol. 4, no. 1, 29 January 2004 (2004-01-29), pages 1 - 12, XP002478754, ISSN: 1471-2407 * |
QIU PING ET AL: "Genome wide in silico SNP-tumor association analysis", BMC CANCER, BIOMED CENTRAL, LONDON, GB, vol. 4, no. 1, 29 January 2004 (2004-01-29), pages 4, XP021004639, ISSN: 1471-2407 * |
SJÖBLOM TOBIAS ET AL: "The consensus coding sequences of human breast and colorectal cancers.", SCIENCE (NEW YORK, N.Y.) 13 OCT 2006, vol. 314, no. 5797, 13 October 2006 (2006-10-13), pages 268 - 274, XP002478760, ISSN: 1095-9203 * |
STRAUSBERG R L: "The Cancer Genome Anatomy Project: new resources for reading the molecular signatures of cancer.", THE JOURNAL OF PATHOLOGY SEP 2001, vol. 195, no. 1, September 2001 (2001-09-01), pages 31 - 40, XP002478759, ISSN: 0022-3417 * |
STRAUSBERG ROBERT L ET AL: "Sequence-based cancer genomics: Progress, lessons and opportunities.", NATURE REVIEWS GENETICS, vol. 4, no. 6, June 2003 (2003-06-01), pages 409 - 418, XP002478757, ISSN: 1471-0056 * |
Also Published As
Publication number | Publication date |
---|---|
WO2007109797A2 (en) | 2007-09-27 |
CA2646194A1 (en) | 2007-09-27 |
EP2004862A2 (en) | 2008-12-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1120292T1 (en) | RNA Intermediated Interference Inhibition of Gene Expression Using Short Interfering Nucleic Acid (siNA) | |
WO2013063155A3 (en) | Companion diagnostic for anti-hyaluronan agent therapy and methods of use thereof | |
WO2012061835A3 (en) | Apparatus and method for non-invasively detecting diseases that affect structural properties in biological tissues | |
MX2010002113A (en) | Methods for detecting oligonucleotides. | |
WO2008008515A3 (en) | Methods and compositions for detecting rare cells from a biological sample | |
WO2003070884A3 (en) | RNA INTERFERENCE MEDIATED INHIBITION OF MDR P-GLYCOPROTEIN GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) | |
WO2006127861A3 (en) | Diagnosis of diseases and conditions by analysis of histopathologically processed biological samples using liquid tissue preparations | |
WO2003070918A3 (en) | Rna interference by modified short interfering nucleic acid | |
WO2012054639A3 (en) | Nmr systems and methods for the rapid detection of analytes | |
WO2003070910A3 (en) | INHIBITION OF VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) AND VEGF RECEPTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) | |
WO2004111190A3 (en) | IN VIVO HIGH THROUGHPUT SELECTION OF EFFECTIVE RNAi PROBES | |
ATE461294T1 (en) | BREAST CANCER DIAGNOSTIC PROCEDURES | |
WO2006084299A3 (en) | Method for evaluating the allergen sensitivity of an individual | |
ATE414277T1 (en) | METHOD FOR PREVENTING TIME-DEPENDENT RNA EXPRESSION IN BIOLOGICAL CELLS | |
Fava et al. | miR-155 expression in primary cutaneous T-cell lymphomas (CTCL) | |
AU2006228990A8 (en) | A method of diagnosis and treatment and agents useful for same | |
WO2007109797A3 (en) | Cancer detection reagents and uses in pathology and diagnostics and cancer cell death | |
EP1522583A3 (en) | RNA interference mediated inhibition of placental growth factor gene expression using short interfering nucleic acid (sina) | |
WO2011139842A3 (en) | Nucleic acid compounds for inhibiting fgfr3 gene expression and uses thereof | |
WO2011069058A8 (en) | Methods for predicting and treating a sterile inflammation and discriminating between sterile and infective inflammation | |
WO2007101664A3 (en) | Improved aspergillosis test in clinical samples | |
NZ622418A (en) | Molecular detection assay | |
WO2009143023A3 (en) | Neoplasia targeting peptides and methods of using the same | |
EP1710307A3 (en) | RNA interference mediated inhibition of gene expression using short interfering nucleic acid (siNA) | |
WO2007013359A3 (en) | Cancer related gene rasgef1a |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200780018777.9 Country of ref document: CN |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2009503183 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2646194 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007780473 Country of ref document: EP |